Treatment of primary defective iron-reutilization syndrome: Revisited

Annals of Hematology

Volumn 79, Issue 8, 2000, Pages 465-468

  Besa, E C ^a   Kim, P W ^a   Haurani, F I ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

ACD; Danazol; Primary defective iron reutilization syndrome

Indexed keywords

ANDROGEN; DANAZOL; FERRITIN; IRON;

AGED; ARTICLE; BONE MARROW; CASE REPORT; DRUG TOLERABILITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON THERAPY; METABOLIC DISORDER; PRIORITY JOURNAL; SIDE EFFECT;

AGED; ANEMIA, IRON-DEFICIENCY; COHORT STUDIES; DANAZOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; IRON; MIDDLE AGED;

EID: 0033869260     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000180     Document Type: Article

References (17)

1. Schilling RF (1991) Anemia of chronic disease: a misnomer. Ann Intern Med 115 : 572-573
2. Erslev AJ (1990) Erythrokinetics. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds) Hematology 4th edn. McGraw Hill, New York, pp 414-422
3. Haurani FI, Green D, Wilcher S (1967) Primary defective iron reutilization. Am J Med 42 : 151-158
4. Haurani FI, Green D, Young K (1965) Iron absorption in hypoferremia. Am J Med Sci 249 : 537-547
5. Means RT, Krantz SB (1992) Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80 : 1639-1647
6. Johnson RA, Waddelow TA, Caro J, Oliff A, Roodman JD (1989) Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 74 : 130
7. Baer AN, Dessypris EM, Goldwasser E, Krantz SB (1987) Blunted erythropoietin response to anemia in rheumatoid arthritis. Br J Haematol 66 : 559
8. Birgegard G (1989) Erythropoiesis and inflammation. Contrib Nephrol 76 : 330-339
9. Kling PJ, Dragsten PR, Roberts RA, Dos Santos B, Brooks D, Hedlund BE, Taetle R (1996) Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancy. Br J Haematol 95 : 241
10. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL (1990) Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322 : 1689-1692
11. Pincus T, Olsen NJ, Russell IJ, Wolfe F, Harris ER, Schnitzer TJ, Boccagno JA, Krantz SB (1990) Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89 : 161-168
12. Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasche C, Lochs H, Raedler A (1996) Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 334 : 619-623
13. Besa EC (1994) Hematologic effects of androgens revisited: an alternative therapy in various hematologic conditions. Semin Hematol 31 : 134-145
14. Reeves WB, Fairman RM, Haurani FI (1981) Influence of hormones on the release of iron by macrophages. J Reticuloendothelial Soc 29 : 173-179
15. Haurani FI, Quinn TJ (1990) Modulators of macrophage transferrin or transferrin-like protein. Mol and Cell Biochem 95 : 49-53
16. Dmowski WP (1990) Danazol, a synthetic steroid with diverse biologic effects. J Reprod Med 35 : 69-75
17. Donaldson VH (1989) Danazol. Am J Med 87[3N]:49N-55N